DT388IL3 fusion protein
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for DT388IL3 fusion protein, covering 2019-04-23 to 2019-04-23. Get the full timeline:
Most recent: Clinical Trial Update: DT388IL3 Fusion Protein in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes [Phase 1, Phase 2]